Researchers normally use a radioactive label to track red blood cell survival. But this method is deemed unsafe for infants and children. So an alternative method - one using biotin to label the cells, instead of radioactive Chromium 51 - is good news for pediatrics. Dr. Jack Widness and colleagues from the University of Iowa have tested the biotin labeling method on a group of critically ill premature babies. In this podcast Dr. Widness presents their results and explains how the method could be used to improve transfusion practices for infants with anemia.

Hosted on Acast. See acast.com/privacy for more information.